Ranajoy Sarkar

Vice President, Head of Business Development (Nasdaq: NBSE) at NeuBase Therapeutics - Pittsburgh, PA, US

Ranajoy Sarkar's Contact Details
HQ
N/A
Location
Montgomery,New Jersey,United States
Company
NeuBase Therapeutics
Ranajoy Sarkar's Company Details
NeuBase Therapeutics logo, NeuBase Therapeutics contact details

NeuBase Therapeutics

Pittsburgh, PA, US • 50 - 99 Employees
Major Drugs

NeuBase is developing ultra precision genetic medicines targeting rare, monogenic diseases, for which there are no approved therapies, as well as more common genetic disorders, including cancers that are resistant to current therapeutic approaches. NeuBase's pipeline includes therapeutic candidates for the treatment of myotonic dystrophy type 1 (DM1), Huntington's disease (HD), and cancer-driving point mutations in KRAS G12V and G12D, which are involved in many tumor types and have historically been "undruggable."

Biotechnology Gene Silencing Antisense Oligonucleotide Therapies Rare Disease Genetic Disease Huntington's Disease Myotonic Dystrophy CNS Disease Huntington's Disease
Details about NeuBase Therapeutics
Frequently Asked Questions about Ranajoy Sarkar
Ranajoy Sarkar currently works for NeuBase Therapeutics, Inc..
Ranajoy Sarkar's role at NeuBase Therapeutics, Inc. is Vice President, Head of Business Development (Nasdaq: NBSE).
Ranajoy Sarkar's email address is ***@neubasetherapeutics.com. To view Ranajoy Sarkar's full email address, please signup to ConnectPlex.
Ranajoy Sarkar works in the Pharmaceuticals industry.
Ranajoy Sarkar's colleagues at NeuBase Therapeutics are Valentina Caro, Mykaela Wagner, Bridget Sawyer-Revels, Thomas Zengeya, Dani Stoltzfus, Barry Badeau, Ramesh Batwal and others.
Ranajoy Sarkar's phone number is N/A
See more information about Ranajoy Sarkar